
USFDA APPLICATION NUMBER - 21794 / DOSAGE - GEL;TOPICAL - 5%
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DAPSONE(UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) | DAPSONE | 50mg in 1 |
Inactive Ingredients
| Ingredient Name | Allergan, Inc. | Encube Ethicals Private Limited |
|---|---|---|
| CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)(4Q93RCW27E) | ||
| CARBOMER HOMOPOLYMER TYPE C(4Q93RCW27E) | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER(A1A1I8X02B) | ||
| METHYLPARABEN(A2I8C7HI9T) | ||
| SODIUM HYDROXIDE(55X04QC32I) | ||
| WATER(059QF0KO0R) |